EGFR and breast carcinoma: In the study by Sui et al., 2016, Luteolin was shown to inhibit cancer cell proliferation and cause suppression in the expressions of p-STAT3, p-EGFR, p-Akt, and p-Erk1/2 in the MCF-7 breast cancer cells that EGF induces [118].